Viewing Study NCT00106665



Ignite Creation Date: 2024-05-05 @ 11:39 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00106665
Status: COMPLETED
Last Update Posted: 2016-01-18
First Post: 2005-03-28

Brief Title: New Onset Weakness in Critically Ill Patients and the Risk of Death and Recurrent ICU Admission
Sponsor: Naeem Ali MD
Organization: Ohio State University

Study Overview

Official Title: Intensive Care UnitICU-Acquired Paresis and the Risk for Mortality and Recurrent ICU Admission Weakness and ICU Readmission Evaluation-WIRE
Status: COMPLETED
Status Verified Date: 2016-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study seeks to define the morbidity of critical care polyneuropathy and to confirm that this diagnosis is in fact independently associated with increased mortality Secondary information regarding the reasons for ICU readmission in patients with weakness may help in formulating cogent discharge strategies for these patients Measurement of weakness using handgrip strength may provide a useful surrogate marker for weakness that may be more easily and uniformly applied

Primary hypothesis

The development of ICU-associated weakness is independently associated with excess attributable mortality

Secondary hypothesis

The development of ICU-associated weakness is associated with an increased need for ICU readmission
Readmission to the ICU will be a result of the development of recurrent respiratory failure or insufficiency
Handgrip strength testing will detect ICU-associated weakness with an equivalent sensitivity as the comprehensive bedside muscle strength exam
Detailed Description: Study Overview This study will enroll patients requiring prolonged mechanical ventilation to identify the presence of newly acquired weakness in the ICU Eligible patients are those that require the use of mechanical ventilation for greater than or equal to five days because this is a significant risk factor for weakness These patients will be enrolled and followed to detect the true relative mortality between weak and strong patients in the ICU

To identify patients with relevant and significant weakness this study identifies weakness in patients who survive and return to a state of normal consciousness As such these patients once enrolled need to be screened daily for awakening Once awake an assessment of peripheral muscle strength will be performed with a standard bedside neuromuscular exam and handgrip manometry

Initial Data Collection After consent demographic information and risk factors for neuromuscular disease for each patient will be recorded Blood pressure values and other data regarding the subjects severity of illness will be collected Any previous use of medicines during the current hospitalization that are associated with the development of weakness will be collected as well Also any previous history of other chronic disease known to be associated with weakness eg diabetes immune system deficiency end-stage liver disease or kidney disease will be noted

Screen for awakening SAOnce daily the patient will be assessed for awakening using a standard RASS When the patient awake and able to follow commands they will be assessed for muscle strength exam

Medical Research Council Strength ExamThe examiner will perform their exam on the first day that the patient is eligible by RASS screening This same examiner will return at least twenty hours but no more than forty-eight hours later to perform a repeat exam The exam will be based on the Medical Research Council standard exam Functions assessedUpper extremity wrist flexion arm flexion shoulder abduction Lower extremity ankle dorsiflexion knee extension and hip flexion Handgrip assessment On the same day as the MRC exam the patient will be asked to perform a handgrip maneuver using the Jamar handgrip manometer

Clinical outcomes

Ventilator use Re-intubation Recurrent ICU admission Tracheostomy use ICU Length of Stay and Hospital LOS

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None